{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:50:28Z","timestamp":1790621428284,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R01566X\/1"],"award-info":[{"award-number":["MR\/R01566X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R01566X\/1"],"award-info":[{"award-number":["MR\/R01566X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219542\/Z\/19\/Z"],"award-info":[{"award-number":["219542\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["TS\/R017581\/1"],"award-info":[{"award-number":["TS\/R017581\/1"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["TS\/R017581\/1"],"award-info":[{"award-number":["TS\/R017581\/1"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The increase in metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH) is a worldwide healthcare challenge. Heterogeneity between men and women in the prevalence and mechanisms of MASLD and MASH is related to differential sex hormone signalling within the liver, and declining hormone levels during aging. In this study we used biochemically characterised pluripotent stem cell derived 3D liver spheres to model the protective effects of testosterone and estrogen signalling on metabolic liver disease \u2018in the dish\u2019. We identified sex steroid-dependent changes in gene expression which were protective against metabolic dysfunction,\u00a0fibrosis, and advanced cirrhosis patterns of\u00a0gene expression, providing new insight into the pathogenesis of MASLD and MASH, and highlighting new druggable targets. Additionally, we highlight gene targets for which drugs already exist for future translational studies.<\/jats:p>","DOI":"10.1186\/s13287-025-04238-0","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:19:50Z","timestamp":1741699190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue"],"prefix":"10.1186","volume":"16","author":[{"given":"Alvile","family":"Kasarinaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jimenez","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Beltran-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena F.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Arede","family":"Rei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Make","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Beniazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Corsinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil C.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Fallowfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa T. K.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7593-5973","authenticated-orcid":false,"given":"David C.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"4","key":"4238_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004.","journal-title":"Hepatology"},{"issue":"11","key":"4238_CR2","first-page":"697","volume":"19","author":"ME Rinella","year":"2023","unstructured":"Rinella ME. Examining the nomenclature change from NAFLD and NASH to MASLD and MASH. Gastroenterology Hepatology. 2023;19(11):697\u20139.","journal-title":"Gastroenterology Hepatology"},{"issue":"8","key":"4238_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/liv.14943","volume":"41","author":"P Burra","year":"2021","unstructured":"Burra P, Bizzaro D, Gonta A, Shalaby S, Gambato M, Morelli MC, Trapani S, Floreani A, Marra F, Brunetto MR, Taliani G, Villa E, Special Interest Group Gender in Hepatology of the Italian Association for the Study of the Liver (AISF). Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Liver Int\u202f: Official J Int Assoc Study Liver. 2021;41(8):1713\u201333. https:\/\/doi.org\/10.1111\/liv.14943.","journal-title":"Liver Int : Official J Int Assoc Study Liver"},{"issue":"4","key":"4238_CR4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.32758","volume":"77","author":"DJH Tan","year":"2023","unstructured":"Tan DJH, Setiawan VW, Ng CH, Lim WH, Muthiah MD, Tan EX, Dan YY, Roberts LR, Loomba R, Huang DQ. Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH. Hepatology. 2023;77(4):1150\u201363. https:\/\/doi.org\/10.1002\/hep.32758.","journal-title":"Hepatology"},{"issue":"12","key":"4238_CR5","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/cells12121604","volume":"12","author":"A Kasarinaite","year":"2023","unstructured":"Kasarinaite A, Sinton M, Saunders PTK, Hay DC. The Influence of sex hormones in liver function and disease. Cells. 2023;12(12):1604. https:\/\/doi.org\/10.3390\/cells12121604.","journal-title":"Cells"},{"issue":"1","key":"4238_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","volume":"65","author":"J McKenzie","year":"2006","unstructured":"McKenzie J, Fisher BM, Jaap AJ, Stanley A, Paterson K, Sattar N. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol. 2006;65(1):40\u20134. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02543.x.","journal-title":"Clin Endocrinol"},{"issue":"4","key":"4238_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4254\/wjh.v14.i4.754","volume":"14","author":"R Apostolov","year":"2022","unstructured":"Apostolov R, Gianatti E, Wong D, Kutaiba N, Gow P, Grossmann M, Sinclair M. Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. World J Hepatol. 2022;14(4):754\u201365. https:\/\/doi.org\/10.4254\/wjh.v14.i4.754.","journal-title":"World J Hepatol"},{"key":"4238_CR8","unstructured":"Cleveland Clinic. Hormone Therapy for Menopause: Types, Benefits & Risks. https:\/\/my.clevelandclinic.org\/health\/treatments\/15245-hormone-therapy-for-menopause-symptoms"},{"issue":"1","key":"4238_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/0970-1591.124197","volume":"30","author":"EC Osterberg","year":"2014","unstructured":"Osterberg EC, Bernie AM, Ramasamy R. Risks of testosterone replacement therapy in men. Indian J Urology\u202f: IJU\u202f: J Urological Soc India. 2014;30(1):2\u20137. https:\/\/doi.org\/10.4103\/0970-1591.124197.","journal-title":"Indian J Urology : IJU : J Urological Soc India"},{"issue":"1","key":"4238_CR10","doi-asserted-by":"publisher","first-page":"015009","DOI":"10.1088\/1758-5090\/abbdb2","volume":"13","author":"B Lucendo-Villarin","year":"2020","unstructured":"Lucendo-Villarin B, Meseguer-Ripolles J, Drew J, Fischer L, Ma E, Flint O, Simpson KJ, Machesky LM, Mountford JC, Hay DC. Development of a cost-effective automated platform to produce human liver spheroids for basic and applied research. Biofabrication. 2020;13(1):015009. https:\/\/doi.org\/10.1088\/1758-5090\/abbdb2.","journal-title":"Biofabrication"},{"issue":"2","key":"4238_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100502","volume":"2","author":"J Meseguer-Ripolles","year":"2021","unstructured":"Meseguer-Ripolles J, Kasarinaite A, Lucendo-Villarin B, Hay DC. Protocol for automated production of human stem cell derived liver spheres. STAR protocols. 2021;2(2): 100502. https:\/\/doi.org\/10.1016\/j.xpro.2021.100502.","journal-title":"STAR protocols"},{"issue":"11","key":"4238_CR12","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/s41591-023-02602-2","volume":"29","author":"TJ Kendall","year":"2023","unstructured":"Kendall TJ, Jimenez-Ramos M, Turner F, Ramachandran P, Minnier J, McColgan MD, Alam M, Ellis H, Dunbar DR, Kohnen G, Konanahalli P, Oien KA, Bandiera L, Menolascina F, Juncker-Jensen A, Alexander D, Mayor C, Guha IN, Fallowfield JA. An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. Nat Med. 2023;29(11):2939\u201353. https:\/\/doi.org\/10.1038\/s41591-023-02602-2.","journal-title":"Nat Med"},{"key":"4238_CR13","unstructured":"Qiagen. RT2 ProfilerTM PCR Array Human Fibrosis. https:\/\/geneglobe.qiagen.com\/us\/product-groups\/rt2-profiler-pcr-arrays\/PAHS-120Z"},{"key":"4238_CR14","unstructured":"Promega Corporation. https:\/\/www.promega.co.uk\/"},{"key":"4238_CR15","unstructured":"NanoString. nSolver Advanced Analysis Software (2024). https:\/\/nanostring.com\/products\/ncounter-analysis-system\/nsolver-advanced-analysis-software\/"},{"issue":"5","key":"4238_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41591-020-0844-1","volume":"26","author":"M Slyper","year":"2020","unstructured":"Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, Smillie C, Smith-Rosario G, Wu J, Dionne D, Vigneau S, Jan\u00e9-Valbuena J, Tickle TL, Napolitano S, Su MJ, Patel AG, Karlstrom A, Gritsch S, Nomura M, Waghray A, Regev A. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020;26(5):792\u2013802. https:\/\/doi.org\/10.1038\/s41591-020-0844-1.","journal-title":"Nat Med"},{"issue":"7783","key":"4238_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF, Henderson BEP, Luu NT, Portman JR, Matchett KP, Brice M, Marwick JA, Taylor RS, Efremova M, Vento-Tormo R, Carragher NO, Kendall TJ, Fallowfield JA, Harrison EM, Mole DJ, Wigmore SJ, Newsome PN, Henderson NC. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575(7783):512\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1631-3.","journal-title":"Nature"},{"key":"4238_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.steroids.2014.12.006","volume":"95","author":"A Fabregat","year":"2015","unstructured":"Fabregat A, Marcos J, Ventura R, Casals G, Jimenez W, Reichenbach V, Segura J, Pozo OJ. Formation of \u0394(1) and \u0394(6) testosterone metabolites by human hepatocytes. Steroids. 2015;95:66\u201372. https:\/\/doi.org\/10.1016\/j.steroids.2014.12.006.","journal-title":"Steroids"},{"issue":"3","key":"4238_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.33594\/000000227","volume":"54","author":"S Farruggio","year":"2020","unstructured":"Farruggio S, Cocomazzi G, Marotta P, Romito R, Surico D, Calamita G, Bellan M, Pirisi M, Grossini E. Genistein and 17\u03b2-Estradiol protect hepatocytes from fatty degeneration by mechanisms involving mitochondria, inflammasome and kinases activation. Cellular Physiology biochem\u202f: Int J Exp Cellular Physiology, Biochem, Pharmacology. 2020;54(3):401\u201316.","journal-title":"Cellular Physiology biochem : Int J Exp Cellular Physiology, Biochem, Pharmacology"},{"key":"4238_CR20","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2017.0362","author":"MJ Lyall","year":"2018","unstructured":"Lyall MJ, Cartier J, Thomson JP, Cameron K, Meseguer-Ripolles J, O\u2019Duibhir E, Szkolnicka D, Villarin BL, Wang Y, Blanco GR, Dunn WB, Meehan RR, Hay DC, Drake AJ. Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells. Philosophical Trans Royal Soc London Series B, Biological Sci. 2018. https:\/\/doi.org\/10.1098\/rstb.2017.0362.","journal-title":"Philosophical Trans Royal Soc London. Series B, Biological Sci"},{"issue":"1","key":"4238_CR21","doi-asserted-by":"publisher","first-page":"101931","DOI":"10.1016\/j.isci.2020.101931","volume":"24","author":"MC Sinton","year":"2020","unstructured":"Sinton MC, Meseguer-Ripolles J, Lucendo-Villarin B, Wernig-Zorc S, Thomson JP, Carter RN, Lyall MJ, Walker PD, Thakker A, Meehan RR, Lavery GG, Morton NM, Ludwig C, Tennant DA, Hay DC, Drake AJ. A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis. iScience. 2020;24(1):101931. https:\/\/doi.org\/10.1016\/j.isci.2020.101931.","journal-title":"iScience"},{"issue":"2","key":"4238_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/toxsci\/kfy106","volume":"164","author":"H Li","year":"2018","unstructured":"Li H, Toth E, Cherrington NJ. Alcohol metabolism in the progression of human nonalcoholic steatohepatitis. Toxicological Sci: Off J Soc Toxicology. 2018;164(2):428\u201338. https:\/\/doi.org\/10.1093\/toxsci\/kfy106.","journal-title":"Toxicological Sci: Off J Soc Toxicology"},{"issue":"4","key":"4238_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","volume":"69","author":"F De Chiara","year":"2018","unstructured":"De Chiara F, Heeb\u00f8ll S, Marrone G, Montoliu C, Hamilton-Dutoit S, Ferrandez A, Andreola F, Rombouts K, Gr\u00f8nb\u00e6k H, Felipo V, Gracia-Sancho J, Mookerjee RP, Vilstrup H, Jalan R, Thomsen KL. Urea cycle dysregulation in non-alcoholic fatty liver disease. J Hepatol. 2018;69(4):905\u201315. https:\/\/doi.org\/10.1016\/j.jhep.2018.06.023.","journal-title":"J Hepatol"},{"issue":"4","key":"4238_CR24","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/nu13041314","volume":"13","author":"A Federico","year":"2021","unstructured":"Federico A, Rosato V, Masarone M, Torre P, Dallio M, Romeo M, Persico M. The role of fructose in non-alcoholic steatohepatitis: old relationship and new insights. Nutrients. 2021;13(4):1314. https:\/\/doi.org\/10.3390\/nu13041314.","journal-title":"Nutrients"},{"issue":"5","key":"4238_CR25","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1007\/s11033-021-06461-3","volume":"48","author":"D Koz\u0142owska","year":"2021","unstructured":"Koz\u0142owska D, My\u015bliwiec H, Harasim-Symbor E, Milewska AJ, Chabowski A, Flisiak I. Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis. Mol Biol Rep. 2021;48(5):4421\u20139. https:\/\/doi.org\/10.1007\/s11033-021-06461-3.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"4238_CR26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3892\/ijmm.2020.4479","volume":"45","author":"H Gao","year":"2020","unstructured":"Gao H, Cao Y, Xia H, Zhu X, Jin Y. CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS-induced lipid peroxidation and inflammation. Int J Mol Med. 2020;45(4):1121\u20139. https:\/\/doi.org\/10.3892\/ijmm.2020.4479.","journal-title":"Int J Mol Med"},{"issue":"10","key":"4238_CR27","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1124\/dmd.109.027466","volume":"37","author":"CD Fisher","year":"2009","unstructured":"Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, Cherrington NJ. Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug Metab Disposition: Biological Fate Chem. 2009;37(10):2087\u201394. https:\/\/doi.org\/10.1124\/dmd.109.027466.","journal-title":"Drug Metab Disposition: Biological Fate Chem"},{"issue":"3","key":"4238_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jcmgh.2019.10.008","volume":"9","author":"T Kurahashi","year":"2020","unstructured":"Kurahashi T, Yoshida Y, Ogura S, Egawa M, Furuta K, Hikita H, Kodama T, Sakamori R, Kiso S, Kamada Y, Wang IC, Eguchi H, Morii E, Doki Y, Mori M, Kalinichenko VV, Tatsumi T, Takehara T. Forkhead Box M1 transcription factor drives liver inflammation linking to hepatocarcinogenesis in mice. Cell Mol Gastroenterol Hepatol. 2020;9(3):425\u201346. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.10.008.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"4238_CR29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s12876-021-01984-2","volume":"21","author":"SY Wu","year":"2021","unstructured":"Wu SY, Liao P, Yan LY, Zhao QY, Xie ZY, Dong J, Sun HT. Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma. BMC Gastroenterol. 2021;21(1):416. https:\/\/doi.org\/10.1186\/s12876-021-01984-2.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"4238_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013577","volume":"5","author":"A Bertola","year":"2010","unstructured":"Bertola A, Bonnafous S, Anty R, Patouraux S, Saint-Paul MC, Iannelli A, Gugenheim J, Barr J, Mato JM, Le Marchand-Brustel Y, Tran A, Gual P. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS ONE. 2010;5(10): e13577. https:\/\/doi.org\/10.1371\/journal.pone.0013577.","journal-title":"PLoS ONE"},{"issue":"1","key":"4238_CR31","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41598-021-82315-z","volume":"11","author":"KM Irvine","year":"2021","unstructured":"Irvine KM, Okano S, Patel PJ, Horsfall LU, Williams S, Russell A, Powell EE. Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep. 2021;11(1):2858. https:\/\/doi.org\/10.1038\/s41598-021-82315-z.","journal-title":"Sci Rep"},{"issue":"6","key":"4238_CR32","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/hep.23927","volume":"52","author":"S Sookoian","year":"2010","unstructured":"Sookoian S, Rosselli MS, Gemma C, Burgue\u00f1o AL, Gianotti TF, Casta\u00f1o GO, Pirola CJ. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 promoter. Hepatology. 2010;52(6):1992\u20132000. https:\/\/doi.org\/10.1002\/hep.23927.","journal-title":"Hepatology"},{"issue":"11","key":"4238_CR33","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1111\/liv.14205","volume":"39","author":"PL Eriksen","year":"2019","unstructured":"Eriksen PL, Vilstrup H, Rigbolt K, Suppli MP, S\u00f8rensen M, Heeb\u00f8ll S, Veidal SS, Knop FK, Thomsen KL. Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion. Liver Int\u202f: Off J Int Assoc Study Liver. 2019;39(11):2094\u2013101. https:\/\/doi.org\/10.1111\/liv.14205.","journal-title":"Liver Int : Off J Int Assoc Study Liver"},{"issue":"1","key":"4238_CR34","doi-asserted-by":"publisher","first-page":"6738","DOI":"10.1080\/21655979.2021.1960463","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Ma H, Gao Y, Jin Y, Ning W, Hou Y, Su J. Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2. Bioengineered. 2021;12(1):6738\u201347. https:\/\/doi.org\/10.1080\/21655979.2021.1960463.","journal-title":"Bioengineered"},{"issue":"5","key":"4238_CR35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.hbpd.2023.08.009","volume":"22","author":"A Bhattacharya","year":"2023","unstructured":"Bhattacharya A, Taylor RE, Guo GL. In vivo mouse models to study bile acid synthesis and signaling. Hepatobiliary Pancreat Dis Int\u202f: HBPD INT. 2023;22(5):466\u201373. https:\/\/doi.org\/10.1016\/j.hbpd.2023.08.009.","journal-title":"Hepatobiliary Pancreat Dis Int : HBPD INT"},{"key":"4238_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104214","volume":"83","author":"C Zhang","year":"2022","unstructured":"Zhang C, Shi M, Kim W, Arif M, Klevstig M, Li X, Yang H, Bayram C, Bolat I, Tozlu \u00d6\u00d6, Hac\u0131muftuoglu A, Y\u0131ld\u0131r\u0131m S, Sebhaoui J, Iqbal S, Wei Y, Shi X, Nielsen J, Turkez H, Uhlen M, Boren J, et al. Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning. EBioMedicine. 2022;83: 104214. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104214.","journal-title":"EBioMedicine"},{"issue":"1","key":"4238_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12944-020-01230-w","volume":"19","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yang J, Yang N, Ma J, Lu D, Dong Y, Liang H, Liu D, Cang M. Dlgap1 negatively regulates browning of white fat cells through effects on cell proliferation and apoptosis. Lipids Health Dis. 2020;19(1):39. https:\/\/doi.org\/10.1186\/s12944-020-01230-w.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"4238_CR38","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.7150\/thno.79434","volume":"13","author":"B Hwang","year":"2023","unstructured":"Hwang B, Kwon MG, Cho MJ, Lee NK, Lee J, Lee JW, Oh KJ, Bae KH, Hwang JH, Min JK, Park JG. Hepatic PTP4A1 ameliorates high-fat diet-induced hepatosteatosis and hyperglycemia by the activation of the CREBH\/FGF21 axis. Theranostics. 2023;13(3):1076\u201390. https:\/\/doi.org\/10.7150\/thno.79434.","journal-title":"Theranostics"},{"issue":"2","key":"4238_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2119\/molmed.2011.00183","volume":"18","author":"GJ Zhao","year":"2012","unstructured":"Zhao GJ, Yin K, Yu-chang F, Tang CK. The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. Mol Med. 2012;18(2):149\u201358. https:\/\/doi.org\/10.2119\/molmed.2011.00183.","journal-title":"Mol Med"},{"issue":"1","key":"4238_CR40","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/s12967-023-04569-7","volume":"21","author":"S Pagano","year":"2023","unstructured":"Pagano S, Bakker SJL, Juillard C, Vossio S, Moreau D, Brandt KJ, Mach F, Dullaart RPF, Vuilleumier N. Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study. J Transl Med. 2023;21(1):694. https:\/\/doi.org\/10.1186\/s12967-023-04569-7.","journal-title":"J Transl Med"},{"issue":"10","key":"4238_CR41","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1080\/15548627.2022.2038501","volume":"18","author":"K Tostes","year":"2022","unstructured":"Tostes K, Dos Santos AC, Alves LO, Bechara LRG, Marascalchi R, Macabelli CH, Grejo MP, Festuccia WT, Gottlieb RA, Ferreira JCB, Chiaratti MR. Autophagy deficiency abolishes liver mitochondrial DNA segregation. Autophagy. 2022;18(10):2397\u2013408. https:\/\/doi.org\/10.1080\/15548627.2022.2038501.","journal-title":"Autophagy"},{"issue":"1","key":"4238_CR42","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/14756366.2021.2025362","volume":"37","author":"Y Ren","year":"2022","unstructured":"Ren Y, Li L, Wan L, Huang Y, Cao S. Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists. J Enzyme Inhib Med Chem. 2022;37(1):606\u201315. https:\/\/doi.org\/10.1080\/14756366.2021.2025362.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"5","key":"4238_CR43","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1111\/jcmm.16296","volume":"25","author":"M Al-Mansoob","year":"2021","unstructured":"Al-Mansoob M, Gupta I, Stefan Rusyniak R, Ouhtit A. KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion. J Cell Mol Med. 2021;25(5):2309\u201314. https:\/\/doi.org\/10.1111\/jcmm.16296.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"4238_CR44","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41374-022-00805-8","volume":"102","author":"R Xiang","year":"2022","unstructured":"Xiang R, Liu Y, Fan L, Jiang B, Wang F. RNA adenosine deaminase (ADAR1) alleviates high-fat diet-induced nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome. Laboratory Investigation. 2022;102(10):1088\u2013100. https:\/\/doi.org\/10.1038\/s41374-022-00805-8.","journal-title":"Laboratory Investigation"},{"issue":"1","key":"4238_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/joim.13147","volume":"289","author":"CJ Pirola","year":"2021","unstructured":"Pirola CJ, Garaycoechea M, Flichman D, Casta\u00f1o GO, Sookoian S. Liver mitochondrial DNA damage and genetic variability of Cytochrome b - a key component of the respirasome - drive the severity of fatty liver disease. J Intern Med. 2021;289(1):84\u201396. https:\/\/doi.org\/10.1111\/joim.13147.","journal-title":"J Intern Med"},{"issue":"5","key":"4238_CR46","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1053\/j.gastro.2020.12.011","volume":"160","author":"CA Emdin","year":"2021","unstructured":"Emdin CA, Haas M, Ajmera V, Simon TG, Homburger J, Neben C, Jiang L, Wei WQ, Feng Q, Zhou A, Denny J, Corey K, Loomba R, Kathiresan S, Khera AV. Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene-environment interaction study. Gastroenterology. 2021;160(5):1620-1633.e13. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.011.","journal-title":"Gastroenterology"},{"key":"4238_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13071-015-0650-7","volume":"8","author":"W Zhang","year":"2015","unstructured":"Zhang W, Zhu J, Song X, Xu Z, Xue X, Chen X, Yang X, Li Y, Dong X, Zhou S, Li W, Qian Y, Liu F, Su C. An association of Aquaporin-4 with the immunoregulation of liver pathology in mice infected with Schistosoma japonicum. Parasit Vectors. 2015;8:37. https:\/\/doi.org\/10.1186\/s13071-015-0650-7.","journal-title":"Parasit Vectors"},{"issue":"11","key":"4238_CR48","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.neo.2021.09.005","volume":"23","author":"Z Wang","year":"2021","unstructured":"Wang Z, Hulsurkar M, Zhuo L, Jinbang X, Yang H, Naderinezhad S, Wang L, Zhang G, Ai N, Li L, Chang JT, Zhang S, Fazli L, Creighton CJ, Bai F, Ittmann MM, Gleave ME, Li W. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation. Neoplasia. 2021;23(11):1147\u201365. https:\/\/doi.org\/10.1016\/j.neo.2021.09.005.","journal-title":"Neoplasia"},{"issue":"10","key":"4238_CR49","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/CM9.0000000000002135","volume":"135","author":"H Huang","year":"2022","unstructured":"Huang H, Xu C. Retinol-binding protein-4 and nonalcoholic fatty liver disease. Chin Med J. 2022;135(10):1182\u20139. https:\/\/doi.org\/10.1097\/CM9.0000000000002135.","journal-title":"Chin Med J"},{"key":"4238_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.744825","volume":"8","author":"K Day","year":"2021","unstructured":"Day K, Seale LA, Graham RM, Cardoso BR. Selenotranscriptome network in non-alcoholic fatty liver disease. Front Nutr. 2021;8: 744825. https:\/\/doi.org\/10.3389\/fnut.2021.744825.","journal-title":"Front Nutr"},{"issue":"5","key":"4238_CR51","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/hep.31995","volume":"74","author":"K Kozumi","year":"2021","unstructured":"Kozumi K, Kodama T, Murai H, Sakane S, Govaere O, Cockell S, Motooka D, Kakita N, Yamada Y, Kondo Y, Tahata Y, Yamada R, Hikita H, Sakamori R, Kamada Y, Daly AK, Anstee QM, Tatsumi T, Morii E, Takehara T. Transcriptomics identify thrombospondin\u20102 as a biomarker for NASH and advanced liver fibrosis. Hepatology. 2021;74(5):2452\u201366. https:\/\/doi.org\/10.1002\/hep.31995.","journal-title":"Hepatology"},{"key":"4238_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s13273-023-00336-3","author":"X Fu","year":"2024","unstructured":"Fu X, Chang J, Jiao D, Zhu M, Ma Y. SLIT3 knockdown inhibited TGF-\u03b2-induced hepatic stellate cells activation by down-regulating YAP signal. Mol Cell Toxicol. 2024. https:\/\/doi.org\/10.1007\/s13273-023-00336-3.","journal-title":"Mol Cell Toxicol"},{"issue":"5","key":"4238_CR53","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41418-023-01153-w","volume":"30","author":"I Vitale","year":"2023","unstructured":"Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri ES, Altucci L, et al. Apoptotic cell death in disease-current understanding of the NCCD 2023. Cell Death Differ. 2023;30(5):1097\u2013154. https:\/\/doi.org\/10.1038\/s41418-023-01153-w.","journal-title":"Cell Death Differ"},{"issue":"3","key":"4238_CR54","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/cells8030210","volume":"8","author":"M Cetin","year":"2019","unstructured":"Cetin M, Odabas G, Douglas LR, Duriez PJ, Balcik-Ercin P, Yalim-Camci I, Sayan AE, Yagci T. ROR1 expression and Its functional significance in hepatocellular carcinoma cells. Cells. 2019;8(3):210. https:\/\/doi.org\/10.3390\/cells8030210.","journal-title":"Cells"},{"issue":"2","key":"4238_CR55","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0502","volume":"12","author":"W He","year":"2023","unstructured":"He W, Huang C, Shi X, Wu M, Li H, Liu Q, Zhang X, Zhao Y, Li X. Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis. Endocr Connect. 2023;12(2): e220502. https:\/\/doi.org\/10.1530\/EC-22-0502.","journal-title":"Endocr Connect"},{"key":"4238_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110741","volume":"109","author":"J Sun","year":"2023","unstructured":"Sun J, Jin X, Zhang X, Zhang B. HMGA2 knockdown alleviates the progression of nonalcoholic fatty liver disease (NAFLD) by downregulating SNAI2 expression. Cell Signal. 2023;109: 110741. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110741.","journal-title":"Cell Signal"},{"issue":"6","key":"4238_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109506","volume":"36","author":"T Yagai","year":"2021","unstructured":"Yagai T, Yan T, Luo Y, Takahashi S, Aibara D, Kim D, Brocker CN, Levi M, Motohashi H, Gonzalez FJ. Feedback repression of PPAR\u03b1 signaling by Let-7 microRNA. Cell Rep. 2021;36(6): 109506. https:\/\/doi.org\/10.1016\/j.celrep.2021.109506.","journal-title":"Cell Rep"},{"issue":"6","key":"4238_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000539","volume":"5","author":"NL Heard-Costa","year":"2009","unstructured":"Heard-Costa NL, Zillikens MC, Monda KL, Johansson A, Harris TB, Fu M, Haritunians T, Feitosa MF, Aspelund T, Eiriksdottir G, et al. NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet. 2009;5(6): e1000539. https:\/\/doi.org\/10.1371\/journal.pgen.1000539.","journal-title":"PLoS Genet"},{"issue":"12","key":"4238_CR59","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/metabo12121164","volume":"12","author":"J Xu","year":"2022","unstructured":"Xu J, Zhang K, Qiu B, Liu J, Liu X, Yang S, Xiao X. Decreased hyocholic acid and lysophosphatidylcholine induce elevated blood glucose in a transgenic porcine model of metabolic disease. Metabolites. 2022;12(12):1164. https:\/\/doi.org\/10.3390\/metabo12121164.","journal-title":"Metabolites"},{"issue":"4","key":"4238_CR60","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5152\/tjg.2023.22590","volume":"34","author":"X Liu","year":"2023","unstructured":"Liu X, Wang Y, Li T, Qu Y. Identification of hub genes and immune infiltration in non-alcoholic fatty liver disease -related hepatocellular carcinoma by bioinformatics analysis. Turkish J Gastroenterology\u202f: Off J Turkish Soc Gastroenterology. 2023;34(4):383\u201393. https:\/\/doi.org\/10.5152\/tjg.2023.22590.","journal-title":"Turkish J Gastroenterology : Off J Turkish Soc Gastroenterology"},{"key":"4238_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176262","volume":"963","author":"X Gao","year":"2024","unstructured":"Gao X, Lin Y, Huang X, Lu C, Luo W, Zeng D, Li Y, Su T, Liang R, Ye J. Comprehensive analysis of the role of Netrin G1 (NTNG1) in hepatocellular carcinoma cells. Eur J Pharmacol. 2024;963: 176262. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176262.","journal-title":"Eur J Pharmacol"},{"key":"4238_CR62","doi-asserted-by":"publisher","first-page":"4829697","DOI":"10.1155\/2022\/4829697","volume":"2022","author":"F Sun","year":"2022","unstructured":"Sun F, Lian Y, Wang J, Hu L, Luo J, Yu J. KIF26B in the prognosis and Immune biomarking of various cancers: a pan-cancer study. J Oncology. 2022;2022:4829697. https:\/\/doi.org\/10.1155\/2022\/4829697.","journal-title":"J Oncology"},{"issue":"2","key":"4238_CR63","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/sj.emboj.7600038","volume":"23","author":"T Hisa","year":"2004","unstructured":"Hisa T, Spence SE, Rachel RA, Fujita M, Nakamura T, Ward JM, Devor-Henneman DE, Saiki Y, Kutsuna H, Tessarollo L, Jenkins NA, Copeland NG. Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. EMBO J. 2004;23(2):450\u20139. https:\/\/doi.org\/10.1038\/sj.emboj.7600038.","journal-title":"EMBO J"},{"issue":"7786","key":"4238_CR64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-019-1790-2","volume":"576","author":"V Calvanese","year":"2019","unstructured":"Calvanese V, Nguyen AT, Bolan TJ, Vavilina A, Su T, Lee LK, Wang Y, Lay FD, Magnusson M, Crooks GM, Kurdistani SK, Mikkola HKA. MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature. 2019;576(7786):281\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1790-2.","journal-title":"Nature"},{"issue":"1","key":"4238_CR65","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12881-018-0725-3","volume":"20","author":"C Ling","year":"2019","unstructured":"Ling C, Sui R, Yao F, Wu Z, Zhang X, Zhang S. Whole exome sequencing identified a novel truncation mutation in the NHS gene associated with nance-horan syndrome. BMC Med Genet. 2019;20(1):14. https:\/\/doi.org\/10.1186\/s12881-018-0725-3.","journal-title":"BMC Med Genet"},{"key":"4238_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.625472","volume":"12","author":"J Tang","year":"2021","unstructured":"Tang J, Yan Z, Feng Q, Yu L, Wang H. The roles of neutrophils in the pathogenesis of liver diseases. Front Immunol. 2021;12: 625472. https:\/\/doi.org\/10.3389\/fimmu.2021.625472.","journal-title":"Front Immunol"},{"issue":"6","key":"4238_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24437","volume":"36","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Zhang X, Li F, Wang Y, Wei M. AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer. J Clin Lab Anal. 2022;36(6): e24437. https:\/\/doi.org\/10.1002\/jcla.24437.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"4238_CR68","doi-asserted-by":"publisher","first-page":"17423","DOI":"10.1038\/s41598-021-96869-5","volume":"11","author":"D Wu","year":"2021","unstructured":"Wu D, Li Y, Ren Q, Pei S, Wang L, Yang L, Chong Y, Sun S, Hao J, Feng F. TANC1 methylation as a novel biomarker for the diagnosis of patients with anti-tuberculosis drug-induced liver injury. Sci Rep. 2021;11(1):17423. https:\/\/doi.org\/10.1038\/s41598-021-96869-5.","journal-title":"Sci Rep"},{"key":"4238_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.874457","volume":"12","author":"Q Wu","year":"2022","unstructured":"Wu Q, Shi X, Pan Y, Liao X, Xu J, Gu X, Yu W, Chen Y, Yu G. The Chemopreventive Role of \u03b2-Elemene in Cholangiocarcinoma by Restoring PCDH9 Expression. Front Oncol. 2022;12: 874457. https:\/\/doi.org\/10.3389\/fonc.2022.874457.","journal-title":"Front Oncol"},{"issue":"8","key":"4238_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100774","volume":"13","author":"U Sharma","year":"2020","unstructured":"Sharma U, Barwal TS, Acharya V, Tamang S, Vasquez KM, Jain A. Cancer susceptibility candidate 9 (CASC9): a novel targetable long noncoding RNA in cancer treatment. Translational Oncology. 2020;13(8): 100774. https:\/\/doi.org\/10.1016\/j.tranon.2020.100774.","journal-title":"Translational Oncology"},{"issue":"6","key":"4238_CR71","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.7150\/ijbs.86465","volume":"20","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Luo P, Cao Y, Peng D, Huo S, Guo J, Wang M, Shi W, Zhang C, Li S, Lin L, Lv J. The role of STAT3\/VAV3 in glucolipid metabolism during the development of HFD-induced MAFLD. Int J Biol Sci. 2024;20(6):2027\u201343. https:\/\/doi.org\/10.7150\/ijbs.86465.","journal-title":"Int J Biol Sci"},{"issue":"D1","key":"4238_CR72","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382. https:\/\/doi.org\/10.1093\/nar\/gkx1037.","journal-title":"Nucleic Acids Res"},{"key":"4238_CR73","doi-asserted-by":"publisher","DOI":"10.62476\/abes9s81","author":"E Huseynov","year":"2024","unstructured":"Huseynov E, Khalilov R, Mohamed AJ. Novel nanomaterials for hepatobiliary diseases treatment and future perspectives. Adv Biology Earth Sci. 2024. https:\/\/doi.org\/10.62476\/abes9s81.","journal-title":"Adv Biology Earth Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04238-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04238-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:19:57Z","timestamp":1741699197000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04238-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4238"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04238-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The cell lines, H9 (hESC) and P106 (iPSC), were supplied by WiCell on a service level agreement basis. WiCell is a non-profit organization established in 1999 to advance stem cell technologies through the supply of high-quality cell lines. The stem cell lines used in this study were derived\/produced under informed consent. The H9 line (WA09) has been registered with hPSC Reg which offers the research community, legislators, regulators and the general public an in-depth overview on the current status of human pluripotent stem cell (hPSC) research. The H9 ethics statement is available at the link\u2014. The P106 line (JHU106i) was derived under clinically compliant conditions in a study by Chou et al. (Stem Cells Translational Medicine 2015; 4:320\u2013332, ). The Johns Hopkins University and Institute of Haematology of the Chinese Academy of Medical Sciences institutional review boards both approved the use of anonymous or deidentified human blood samples from consented adult donors and patients to generate the P106 cell line.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DCH is a founder, director and shareholder in Stimuliver ApS and Stemnovate Limited. JAF serves as a consultant or advisory board member for Resolution Therapeutics, Kynos Therapeutics, Ipsen, River 2 Renal Corp., Stimuliver, Galecto Biotech, Global Clinical Trial Partners and Guidepoint and has received research grant funding from Genentech and GlaxoSmithKline.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}